Streetbeat News

Stock Prices

WELL

Evercore ISI Group analyst Steve Sakwa has downgraded Welltower (NYSE:WELL) from Outperform to In-Line and lowered the price target from $82 to $81.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 10:58 am

JPM

JPMorgan's Q2 total markets revenue was $7B, marking a 10% decrease. The Markets & Securities Services revenue was $8.3B, down by 5%.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 10:57 am

WFC

Wells Fargo's shares are trading higher following the company's Q2 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 10:57 am

JPM

JPMorgan Chase reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 10:56 am

ERIC

LESL

LILM

NOK

QBTS

TCOM

THRX

Several stocks including Theseus Pharmaceuticals, Leslie's, Nokia, Ericsson, Lilium, D-Wave Quantum, and Trip.com Group recorded losses in pre-market trading. Theseus Pharmaceuticals announced plans to discontinue a Phase 1/2 study, causing its shares to tumble. Leslie's released preliminary results for its fiscal third quarter and announced a CFO transition, leading to a dip in its shares. Nokia reduced its net sales guidance and narrowed its operating margin outlook for 2023, causing its shares to tumble. Ericsson posted a loss for the second quarter, leading to a decline in its shares. Lilium reported the launch of a public offering of Class A ordinary shares and concurrent private placement offering, causing its shares to fall. D-Wave Quantum's shares declined after surging over 33% on Thursday. Trip.com Group's shares fell despite Benchmark reiterating it with a Buy and maintaining a $55 price target.

Portfolio Pulse from Lisa Levin

July 14, 2023 | 10:55 am

TIXT

TU

TELUS Corp (NYSE:TU) has revised its 2023 outlook, reducing its operating revenue growth to 9.5%-11.5% and adjusted EBITDA growth to 7%-8%. This follows a revised 2023 outlook for TELUS International (Cda) Inc (NYSE:TIXT), which expects Q2 revenue of $660 million-$668 million, a Y/Y decline of 1%, and adjusted EBITDA of $117 million-$120 million. TIXT's 2023 outlook projects revenue of $2.700 billion-$2.730 billion, adjusted EBITDA of $575 million-$600 million, and adjusted EPS of $0.90-$0.97.

Portfolio Pulse from Lekha Gupta

July 14, 2023 | 10:54 am

META

Meta Platforms Inc.'s social media app, Threads, has seen a significant drop in daily active users and time spent on the app since its strong start, where it hit 100 million users in just five days. The decline in engagement metrics suggests that the initial hype around the Twitter-clone may be fading. This could be a significant blow to Meta, especially considering the app's initial success.

Portfolio Pulse from Benzinga Neuro

July 14, 2023 | 10:37 am

CGC

Canopy Growth Corporation (CGC) has been notified by the Nasdaq that it is not in compliance with Listing Rule 5450(A)(1) due to its common shares closing bid price being below $1.00 per share for 30 consecutive business days.

Portfolio Pulse from Charles Gross

July 14, 2023 | 10:35 am

CNTG

Centogene has regained compliance with Nasdaq's listing requirements, avoiding potential delisting.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 10:33 am

FREQ

Korro Bio and Frequency Therapeutics have entered into a definitive merger agreement to combine in an all-stock transaction. The combined company will focus on the advancement of Korro Bio's portfolio of RNA editing programs and will operate under Korro Bio, Inc. It will apply to trade on Nasdaq under the ticker symbol 'KRRO'.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 10:32 am